Mondini Bonora Ginevra successfully assisted a US company leader in the field of dental implantology, in a report to the Ministry of Health, General Directorate of Medical Devices and Pharmaceutical Service, concerning the CE marking of a medical device marketed by a competing company, obtaining, pursuant to Article 20 of Legislative Decree no. 137/2022, therecall order from the market of the product.
The Firm, with a team led by the managing partner Carlo Ginevra and supported by the senior associate Valeria Giugliano, assists the client in a series of actions brought at civil, criminal and administrative level against the same competitor, complaining, among other things, patent infringement And unfair competition.
